|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 10/23/17 Landec Corp/CA 8-K:5,9 10/19/17 2:64K RDG Filings/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 27K 2: EX-99.1 Miscellaneous Exhibit HTML 8K
| lndc20170822_def14a.htm |
Exhibit 99.1
FIRST AMENDMENT
to the
LANDEC CORPORATION
2013 STOCK INCENTIVE PLAN
WHEREAS, Landec Corporation (the “Corporation”) adopted the Landec Corporation 2013 Stock Incentive Plan (the “Plan”), effective October 10, 2013 (the “Effective Date”); and
WHEREAS, the Board of Directors has determined that it is in the best interests of the Corporation and its stockholders to amend the Plan to increase the number of shares of common stock available for issuance under the Plan by 1,000,000 shares from 2,000,000 to 3,000,000, subject to stockholder approval.
NOW THEREFORE, the Plan is hereby amended as follows:
1. Section 5.1 of the Plan is hereby deleted in its entirety and replaced with the following:
“5.1 Basic Limitation. The stock issuable under the Plan shall be authorized but unissued Shares. The aggregate number of Shares reserved for Awards under the Plan shall not exceed 3,000,000 Shares, subject to adjustment pursuant to Section 10. For sake of clarity, all Shares issued and issuable pursuant to any Awards granted under the Plan on or after the Effective Date shall count against the 3,000,000 Share limit. The aggregate maximum number of Shares that may be issued in connection with ISOs shall be 3,000,000 Shares.”
2. This Amendment shall become effective upon stockholder approval. Except as amended herein, the terms of the Plan shall remain in full force and effect.
IN WITNESS WHEREOF, the undersigned has executed this First Amendment to the Landec Corporation 2013 Stock Incentive Plan on August 23, 2017, to become effective upon stockholder approval of this Amendment.
|
|
LANDEC CORPORATION |
|
|
| By: /s/ Molly A. Hemmeter | |||
| Name: Molly A. Hemmeter | |||
| Title: President and Chief Executive Officer | |||
|
|
|
|
|
| This ‘8-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed as of: | 10/23/17 | |||
| Filed on: | 10/20/17 | S-8 | ||
| For Period End: | 10/19/17 | |||
| 8/23/17 | DEF 14A | |||
| 10/10/13 | 8-K, DEF 14A, SC 13G/A | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/20/24 Lifecore Biomedical, Inc./DE 10-K 5/28/23 138:75M 6/06/23 Lifecore Biomedical, Inc./DE S-1/A 2:365K Workiva Inc Wde… FA01/FA 4/06/23 Lifecore Biomedical, Inc./DE S-1 4:527K Workiva Inc Wde… FA01/FA 3/16/23 Lifecore Biomedical, Inc./DE 10-K/A 5/29/22 129:20M 9/14/22 Lifecore Biomedical, Inc./DE 10-K 5/29/22 112:17M 7/29/21 Lifecore Biomedical, Inc./DE 10-K 5/30/21 107:13M 8/14/20 Lifecore Biomedical, Inc./DE 10-K 5/31/20 107:16M |